Glooko Names Mark Clements, M.D., Ph.D. as Chief Medical and Strategy Officer
Renowned pediatric endocrinologist and researcher brings deep clinical and technical expertise to expanded leadership role Palo Alto, CA – May 19, 2025...
Glooko Joins Epic Showroom, Expanding Access to Seamless Electronic Health Record Integration for Healthcare Providers
Palo Alto, CA – February 27, 2025 – Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and...
Glooko and Innovation Zed Partner to Revolutionize Injectable Therapy Management with Digital Companion Apps
Palo Alto, CA – February 6, 2025 – Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and medical...
Glooko Secures Reimbursement for Remote Monitoring of Gestational Diabetes in France
PALO ALTO, Calif. – January 21, 2025 – Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and...
Hedia and Glooko Partner to Elevate Diabetes Management with Personalised Bolus Insulin Dosing
New integration delivers personalised insulin dosing advice, improving care for people with diabetes and enhancing healthcare provider insights. COPENHAGEN,...
Glooko Secures $100 Million Series F Financing and Appoints Mike Alvarez as Chief Executive Officer
Expert health tech leader brings extensive experience in connected care, life sciences and chronic condition management to drive global growth PALO...
Glooko Appoints Enrique Conterno, former Eli Lilly & Company Senior Executive, to Board of Directors
Glooko announced the appointment of Enrique Conterno to its Board of Directors.
Glooko Unveils Redesigned Mobile App
Glooko announced the redesign of its award-winning mobile app for its connected care platform, which will provide a more streamlined diabetes management...
Glooko Announces Partnership with Insulin Dosing Algorithm Company Hedia
Glooko announced a partnership with insulin dosing algorithm company Hedia to provide people with diabetes personalized care and bolus insulin dosing advice.
Glooko Announces Global Collaboration with Sanofi for SoloStar® Pen Connectivity with New Device SoloSmart®
Glooko Inc. announced that they have entered into a partnering agreement with Sanofi to increase their support of people living with diabetes and healthcare...
Glooko Granted ISO 27001 Certification
Glooko received ISO 27001 certification for its data management and remote patient monitoring platforms for people with diabetes and related chronic conditions.
Glooko Earns HITRUST and SOC 2 Type II Certifications
Glooko Inc., announced achieving SOC 2 Type II certification and renewal of HITRUST certification for Glooko®, its industry leading connected care platform...
Glooko Wins Distinguished dotCOMM Award
Glooko was recognized with a distinguished gold dotCOMM Award for its earned media placements and thought leadership on remote patient monitoring.
Glooko Launches Academy™ in Ireland
Glooko announced, in partnership with the Diabetes Technology Network (DTN)/ Association of British Clinical Diabetologists (ABCD), the expansion into...
Glooko Appoints Alfonso “Chito” Zulueta, former Eli Lilly & Company Senior Executive, to Board of Directors
Glooko, Inc. announced the appointment of Alfonso “Chito” Zulueta, a former Eli Lilly & Company senior executive, to its Board of Directors.
Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France
Paris-based health platform provides diabetes remote monitoring and enhances physician-patient collaboration
Glooko Collaborates with Johns Hopkins Medicine HealthCare Solutions on Clinically Proven Digital Health Technology for Chronic Conditions
Combined Offering Provides all the Components of an End-to-End Platform
Glooko Acquires Germany-Based xbird, a Medical AI Company
Acquisition expands Glooko’s digital health capabilities with machine learning
Glooko Announces Collaboration with Novo Nordisk for European Connected Pen Launches
Research Finds Connected Pens Significantly Reduce Missed Doses and Improves Time in Recommended Glucose Range
Glooko Announces New Chief Technology Officer
Glooko Inc., the leading provider of remote patient monitoring and data management platforms in diabetes and related chronic conditions, today announced...
Glooko to Present Patient Outcomes Showing Impact of Remote Patient Monitoring and Coaching on Glycemic Control in Type 2 Diabetes
A study of the use of remote patient monitoring (RPM) with diabetes patients demonstrated improved and sustained glycemic control at 3-, 6- and 12-month...
